Different from the above studies, the latest studies found that ZHX2 promotes tumor growth and migration of renal carcinoma [18] and activates HIF1α oncogenic signaling in triple-negative breast cancer [19]. Here, ZHX2 is linked to triple-negative breast carcinoma.